Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/822-protocol-sakk-1116-personalized-and-cell-based-anti-tumor-immunization-mvx-onco-1-in-advanced-head-and-neck-squamous-cell-carcinoma-a-single-arm-open-label-multicenter-phase-ii-trial